CD4cyt are expanded in patients with heterozygous CTLA4 mutations, and the cytotoxicity of CD4+ T cells is increased in cancer patients after ICI therapy and in a mouse model of acute viral infection after CTLA4 blockade. This evidence concerns the gene CTLA4 and viral infectious disease.